MetaADEDB 2.0 @ LMMD
idraparinux
(MVPQUSQUURLQKF-MCPDASDXSA-E)
Structure
SMILES
CO[C@@H]1[C@@H](OC)[C@H](O[C@@H]2[C@@H](COS(=O)(=O)[O-])O[C@@H]([C@@H]([C@H]2OS(=O)(=O)[O-])OS(=O)(=O)[O-])O[C@@H]2[C@@H](O[C@H]([C@@H]([C@H]2OC)OC)O[C@@H]2[C@@H](COS(=O)(=O)[O-])O[C@@H]([C@@H]([C@H]2OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC)C(=O)[O-])O[C@@H]([C@H]1O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@H]([C@@H]([C@H]1OC)OC)OC)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Molecular Formula:
C38H55Na9O49S7
Molecular Weight:
1727.180
Log P:
-5.2195
Hydrogen Bond Acceptor:
49
Hydrogen Bond Donor:
0
TPSA:
760.84
CAS Number(s):
149920-56-9
Synonym(s)
1.
idraparinux
2.
ORG 34006
3.
ORG-34006
4.
SANORG 34006
5.
SANORG-34006
6.
SR 34006
7.
SR-34006
8.
SR34006
9.
idraparinux sodium
External Link(s)
MeSHC479958
PubChem Compound3083444
KEGGdr:D10471
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Embolism and Thrombosis16084352CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.